title: Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery.
authors.affiliation: Angers, France.
authors.forename: E
authors.initials: E
authors.lastname: Rineau
authors.affiliation: Angers, France.
authors.forename: A
authors.initials: A
authors.lastname: Chaudet
authors.affiliation: Angers, France.
authors.forename: L
authors.initials: L
authors.lastname: Carlier
authors.affiliation: Angers, France.
authors.forename: P
authors.initials: P
authors.lastname: Bizot
authors.affiliation: Angers, France sigismond@lasocki.com.
authors.forename: S
authors.initials: S
authors.lastname: Lasocki
mesh_terms: D000368:Aged; D004357:Drug Synergism; D017558:Elective Surgical Procedures; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005290:Ferric Compounds / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007501:Iron / Q000097:blood; D000090463:Iron Deficiencies; D008297:Male; D008320:Maltose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D019637:Orthopedic Procedures / Q000379:methods*; D011300:Preoperative Care; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D005290:Ferric Compounds; D006397:Hematinics; D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa; C522335:ferric carboxymaltose; D008320:Maltose; D007501:Iron